Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions

Abstract

Nonmelanoma skin cancer (NMSC) is the most common malignancy occurring in white populations. It is currently becoming an important challenge in terms of public health management as the increasing incidence rates will probably have a tremendous impact on healthcare costs. Possible factors driving this rise in NMSC numbers are increases in both acute and prolonged UV exposure together with increasing numbers of older people in the population. A better understanding of NMSC epidemiology in Europe is essential if an evidence-based European-wide public health policy is to be developed. It is obvious this can only be achieved by recording and analysing comparative epidemiological data. Finally, by improving the skin examination training for physicians, developing guidelines and exchanging best practices, a high level of healthcare could be provided for NMSC.

In vivo measurements of diffuse reflectance and time‐resolved autofluorescence emission spectra of basal cell carcinomas

“…In the UK and the USA respectively, there are approximately 100,000 and 1,000,000 new cases reported every year [1,2]. Additionally, amongst white populations in Europe, the USA, Canada and Australia the average increase in NMSC has been between 3 and 8% per year since the 1960s [3,4].…”

Advanced Squamous Cell Carcinoma of the Skin

“…The patients are typically old, with risk conditions to skin carcinomas (chronic U.V. exposition and fair skin) and may have other local disease as burn scars, chronic skin ulcer and systemic pathologies related to immune system suppression (organ transplant receptors, hematopoietic disorders) (Cherpelis, Marcusen et al 2002;Trakatelli, Ulrich et al 2007). Low economic and educational status or difficult access to the health system may also play a role to the presentation of advanced cases, but not confirmed in studies.…”

Prevalencia de Queilitis Actínica en Pescadores Artesanales, Valdivia, Chile

“…En un estudio prospectivo de 12 meses, se determinó una incidencia de transformación maligna de QA en CEC invasivo de un 0,24 % (Marks et al, 1986). No obstante, se ha determinado que el riesgo de progresión maligna en 10 años sería de un 6,1 % a un 10,2 % (Trakatelli et al, 2007) incrementándose a un 40 % en pacientes inmunocomprometidos (Fuchs & Marmur, 2007). Se debe mencionar además, que sobre el 80 % de los casos de CEC invasivos ubicados en zonas expuestas a la RUV se desarrollan en relación a una lesión de QA preexistente (Ferrándiz et al, 2014).…”